Xcout Intel
Nuritas competitors & alternatives
The 12 closest competitors and alternatives to Nuritas among biotech companies — ranked by similarity to what Nuritas actually does, not by market-cap band.
Subscribe to see Nuritas’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Nuritas
Nuritas uses a proprietary AI platform to discover, validate, and supply natural peptide ingredients for oral and topical health and wellness formulations. The company serves health and wellness brands by providing clinically-backed ingredients and custom peptide discovery services.
Nuritas at a glance
Nuritas is a biotech company headquartered in Ireland. Xcout tracks 11 named people at Nuritas, including Conor Walshe (Chief Financial Officer). Xcout recorded 1 job posting from Nuritas in the last 90 days.
Nuritas leadership
- Conor WalsheChief Financial Officer
- Alison AndersonChief People Officer
- Brian KeoghChief Science Officer (Interim)
- Emily RossChief Brand Officer
- John CaseyChief Manufacturing & Supply Chain Officer
- Dr. Alan BartonChairman
5 more named people on record for Nuritas, with roles, board committees and tenure — see the full roster →
Hiring at Nuritas
Xcout recorded 1 job posting from Nuritas in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Nuritas's hiring signals →
Recent Nuritas news
Top 12 Nuritas competitors
Ranked by semantic similarity — how close each company is to Nuritas by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
Genvor Inc utilizes an AI-accelerated peptide platform to develop sustainable agricultural solutions and human health wellness products. The company serves agricultural partners through licensing and co-development to improve crop protection, stress tolerance, and yields, while also providing targeted peptide products for consumer recovery, performance, anti-aging, and daily wellness.
Biotechnology
Meddenovo Drug Design is a Lyon, France-based biotechnology company operating at the intersection of AI and life sciences to build advanced computational technologies for peptide drug discovery.
Biotechnology
Cime Therapeutics Inc. is a chemistry-first company that provides an automated synthesis platform integrating artificial intelligence and machine learning for drug discovery. The company serves the pharmaceutical and biotechnology sectors by producing novel therapeutic molecules, such as small molecules, molecular glues, and covalent compounds, at high speed and scale.
Similar biotech company
Peptilogics, Inc. is a biotechnology company founded in 2013 and headquartered in Pittsburgh, Pennsylvania. The company utilizes advanced computational and biological approaches to discover and develop novel peptide therapeutics.
Biotechnology
Bonito Biosciences is a life-science company headquartered in Waltham, Massachusetts, building a delivery ligand discovery platform that combines encoded libraries, functional live-cell selections, and AI.
Similar biotech company
General Biotechnologies develops programmable synthetic biology platforms that use edible microbes to manufacture and deliver peptide therapeutics. The company primarily serves the pharmaceutical industry by reformulating discontinued peptide drugs into low-cost, needle-free oral medications and providing field-deployable biomanufacturing kits.
Similar biotech company
Metis TechBio Co., Ltd., founded in 2020 and headquartered in Beijing, China, (previously Hangzhou Jitai Pharmaceutical Technology Co., Ltd.) specializes in the advanced research and development of AI-powered nanomaterials. The company's core mission is to facilitate the delivery and application of active agents within carbon-based life forms, operating in both the Chinese Mainland and the United States. Central to its offerings is NanoForge, a comprehensive suite of interconnected technologies that includes a novel lipid library, foundational artificial intelligence models, METiSAIAgent, cutting-edge quantum chemistry and molecular dynamics simulations, and AI-driven screening platforms. Furthermore, Metis TechBio has developed specialized platforms like AiTEM, AiLNP, and AiRNA. These tools are crucial for simulating, predicting, and interpreting interactions at the nanoscale, thereby enabling the precise design, optimization, and validation of sophisticated nanomaterials and their associated payloads. The company provides its services through a three-tiered system: a foundational dry-wet data layer supported by integrated laboratory infrastructure, a model layer featuring METiS AI foundational models, and an application layer known as METiSAgentv. Metis TechBio primarily serves a diverse clientele, including pharmaceutical companies, biotechnology firms, and medical research institutions.
Similar biotech company
Enveda Biosciences (Enveda Therapeutics Inc.) is a biotechnology research company headquartered in Boulder, Colorado. The company leverages artificial intelligence to discover novel therapeutics and chemical compounds derived from natural sources.
Similar biotech company
Nosis Biosciences develops receptor-targeted RNA medicines utilizing its proprietary AI-powered platform, Connexa, which combines physics-aware deep learning, single cell biology, and high-throughput chemistry. The company's platform designs gene-silencing therapeutics intended to treat chronic conditions across various cell types and organ systems, including the heart, lungs, kidneys, and brain.
Similar biotech company
Cyclica was a Toronto, Canada-based biotechnology company that developed AI and machine-learning software for drug discovery, including predicting drug–protein interactions and identifying potential off-target effects. It served pharmaceutical and biotechnology companies seeking to accelerate small-molecule discovery and improve drug-candidate design.
Similar biotech company
Launched in 2022 and headquartered in Seattle, Washington, Vilya is an AI peptide company co-founded by scientists from the Institute of Protein Design. The company uses artificial intelligence and synthetic biology to design novel macrocycle therapeutics inspired by nature.
Biotechnology
NeuroInitiative is a computational biology company that uses a patented AI simulation platform to identify and prioritize drug targets for neurodegenerative and age-related diseases. The company develops therapeutic pipelines, such as its spinout Vincere Biosciences, focusing on treatments for conditions like Parkinson's disease.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Nuritas and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Nuritasand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →